drugset / Trial / NCT00335881

Persistence of the Immune Response to Hepatitis B in 4-6 Years Old Children Previously Vaccinated With DTPa-HBV-IPV/Hib

NCT00335881

Phase 4 Completed 300 enrolled GlaxoSmithKline
Non-randomizedParallel-groupOpen-labelPrevention

Summary

Persistence of seroprotective antibody concentrations \& immunological memory shown by the ability to mount a response to a challenge dose of HBV vaccine

Timeline

Start
2006-06
Primary completion
Completion
2006-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Hepatitis B vaccine Vaccine